• Explore /
  • Poster
  • / Effect on outcomes of toxicity-related dose reduction in TKI monotherapy or TKI-IO combination therapy for advanced renal cell carcinoma.

Effect on outcomes of toxicity-related dose reduction in TKI monotherapy or TKI-IO combination therapy for advanced renal cell carcinoma.

Abstract Poster

Authors

null

Giacomo Nuvola

Department of Experimental, Diagnostic, and Specialty Medicine, S.Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy

Giacomo Nuvola , David Humberto Marmolejo Castañeda , Veronica Mollica , Matteo Santoni , Victor Navarro Garces , Macarena González , Rafael Morales-Barrera , Joan Carles , Francesco Massari , Cristina Suárez

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4528)

DOI

10.1200/JCO.2023.41.16_suppl.4528

Abstract #

4528

Poster Bd #

20

Abstract Disclosures

Similar Posters

First Author: Aung Naing

Poster

2024 ASCO Genitourinary Cancers Symposium

Toxicity-benefit analysis of advanced prostate cancer trials using weighted toxicity scoring.

Toxicity-benefit analysis of advanced prostate cancer trials using weighted toxicity scoring.

First Author: Jaspreet Kaur Gill

First Author: Carissa Beaulieu

First Author: Carolina Alves Costa Silva